Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05015439

Cannabidiol (CBD) in Adults With ASD

Conditions: Autism Spectrum Disorder

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 40
Sponsor: Johns Hopkins University

Location: JHBMC Baltimore Maryland

Summary

There are no FDA approved treatments for use in adults with autism spectrum disorder (ASD), many of whom have distressing anxiety, mood disturbances, sleep problems, and agitation. Some researchers and individuals with ASD have noted that cannabidiol (CBD) is beneficial for those psychiatric problems. This study is to learn more about the effectiveness and safety of CBD in the treatment of psychiatric problems in adults with ASD. The study will last 14 weeks total, during which six weeks participants will receive a pill containing CBD, two weeks where participants will receive no drug/placebo, and six weeks where participants will receive the placebo, an inactive pill. As part of the study, participants will have regular visits and be asked questions about anxiety, challenging behaviors, daily functioning, cognition, and physical symptoms, on standard assessments.

Eligibility Criteria

Inclusion Criteria: * ASD based on Diagnostic Statistical Manual 5 (DSM-5) criteria * a significant mood disorder, sleep disturbance, or exhibit agitation, aggression, or other aberrant behavior that is interfering with function and quality of life, as determined by their psychiatric interview Exclusion Criteria: * history of alcohol or substance use disorder * positive urine tetrahydrocannabinol screen at onset of study * individuals who are pregnant, lactating, or planning pregnancy during or within three months of completing the trial * individuals with unstable liver disease * individuals taking medications where CBD interaction might significantly alter drug levels, such as clobazam

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05015439). StuddyBuddy aggregates publicly available trial information.